{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:16Z","timestamp":1791936016421,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nano.2026.102996","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:54:35Z","timestamp":1784271275000},"page":"102996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microneedle-mediated drug delivery systems for brain diseases"],"prefix":"10.1016","volume":"76","author":[{"given":"Jia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fashan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102996_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.102996_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120351","article-title":"Evolving new-age strategies to transport therapeutics across the blood-brain-barrier","volume":"599","author":"Choudhari","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102996_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers Cns"},{"key":"10.1016\/j.nano.2026.102996_bb0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2026.102996_bb0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13311-017-0520-4","article-title":"Convection-enhanced delivery","volume":"14","author":"Mehta","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nano.2026.102996_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nbt.1866","article-title":"Intranasal delivery to the brain","volume":"29","author":"Henkin","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2026.102996_bb0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresbull.2018.08.003","article-title":"Ligand conjugation: an emerging platform for enhanced brain drug delivery","volume":"142","author":"Nabi","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.nano.2026.102996_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115326","article-title":"Long-acting transdermal drug delivery formulations: current developments and innovative pharmaceutical approaches","volume":"210","author":"Karve","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102996_bb0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/mi11110961","article-title":"Microneedles: Characteristics, materials, production methods and commercial development","volume":"11","author":"Tucak","year":"2020","journal-title":"Micromachines"},{"key":"10.1016\/j.nano.2026.102996_bb0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","article-title":"Microfabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Henry","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0055","series-title":"Augmenting Convection-enhanced Delivery Through Simultaneous Co-delivery of Fluids and Laser Energy With a Fiberoptic Microneedle Device","first-page":"85760G","author":"Hood","year":"2013"},{"key":"10.1016\/j.nano.2026.102996_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejpb.2016.06.006","article-title":"Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer\u2019s disease","volume":"105","author":"Kim","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102996_bb0065","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/adfm.201102012","article-title":"Fabrication of silk microneedles for controlled-release drug delivery","volume":"22","author":"Tsioris","year":"2012","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0070","doi-asserted-by":"crossref","first-page":"68388","DOI":"10.1021\/acsami.4c16024","article-title":"A combinatorial approach with microneedle pretreatment and thermosensitive gel loaded with rivastigmine lipid nanoparticle formulation enables brain delivery via the trigeminal nerve","volume":"16","author":"Permana","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102996_bb0075","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Exp Opin Drug Deliv"},{"key":"10.1016\/j.nano.2026.102996_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nature16492","article-title":"Bioresorbable silicon electronic sensors for the brain","volume":"530","author":"Kang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nano.2026.102996_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12668-026-02594-6","article-title":"Microneedle-based transdermal delivery for Parkinson\u2019s disease: a paradigm shift in patient-centric therapy","volume":"16","author":"Chhabada","year":"2026","journal-title":"BioNanoSci"},{"key":"10.1016\/j.nano.2026.102996_bb0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2018.03.031","article-title":"3D printed microneedles for insulin skin delivery","volume":"544","author":"Pere","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102996_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: a smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2026.102996_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2024.01.013","article-title":"Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer\u2019s disease treatment","volume":"366","author":"Ruan","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102996_bb0105","doi-asserted-by":"crossref","first-page":"2106606","DOI":"10.1002\/adma.202106606","article-title":"Silk microneedle patch capable of on-demand multidrug delivery to the brain for glioblastoma treatment","volume":"34","author":"Wang","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jconrel.2021.08.057","article-title":"Microneedle-mediated vascular endothelial growth factor delivery promotes angiogenesis and functional recovery after stroke","volume":"338","author":"Liu","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102996_bb0115","doi-asserted-by":"crossref","first-page":"44518","DOI":"10.1021\/acsami.4c09394","article-title":"Albumin-based microneedles for spatiotemporal delivery of temozolomide and niclosamide to resistant glioblastoma","volume":"16","author":"Yang","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102996_bb0120","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1021\/acs.analchem.4c00483","article-title":"Rapid glutathione analysis with SERS microneedles for deep glioblastoma tissue differentiation","volume":"96","author":"Zhang","year":"2024","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2026.102996_bb0125","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-023-39745-2","article-title":"Porous microneedle patch with sustained delivery of extracellular vesicles mitigates severe spinal cord injury","volume":"14","author":"Fang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102996_bb0130","series-title":"The Blood-brain and Blood-tumor barriers: A Review of Strategies for Increasing Drug Delivery","author":"Groothuis","year":"2000"},{"key":"10.1016\/j.nano.2026.102996_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00418-008-0410-2","article-title":"Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat","volume":"130","author":"Wolburg","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.nano.2026.102996_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain via the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102996_bb0145","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102996_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0155","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102996_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/pharmaceutics11110598","article-title":"Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration","volume":"11","author":"Lochhead","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102996_bb0165","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/17425247.2014.938635","article-title":"The role of microneedles for drug and vaccine delivery","volume":"11","author":"Quinn","year":"2014","journal-title":"Exp Opin Drug Deliv"},{"key":"10.1016\/j.nano.2026.102996_bb0170","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102996_bb0175","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nano.2026.102996_bb0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.nano.2026.102996_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/10738584241259773","article-title":"Breaking down glioma-microenvironment crosstalk","volume":"31","author":"Ramachandran","year":"2025","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nano.2026.102996_bb0190","first-page":"7","article-title":"Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas","author":"Gieryng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102996_bb0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneurol.2011.2910","article-title":"Addressing diffuse glioma as a systemic brain disease with single-cell analysis","volume":"69","author":"Sahm","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nano.2026.102996_bb0200","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.nano.2026.102996_bb0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nano.2026.102996_bb0210","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jconrel.2020.11.022","article-title":"Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma","volume":"328","author":"McCrorie","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102996_bb0215","doi-asserted-by":"crossref","first-page":"2411869","DOI":"10.1002\/adma.202411869","article-title":"Self\u2011oxygenating PROTAC microneedle for spatiotemporally-confined protein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0220","doi-asserted-by":"crossref","first-page":"2426444","DOI":"10.1080\/14686996.2024.2426444","article-title":"GelMA microneedle-loaded bio-derived nanovaccine shows therapeutic potential for gliomas","volume":"25","author":"Qin","year":"2024","journal-title":"Sci Technol Adv Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0225","doi-asserted-by":"crossref","first-page":"2409857","DOI":"10.1002\/adma.202409857","article-title":"Implantable microneedle-mediated eradication of postoperative tumor foci mitigates glioblastoma relapse","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0230","doi-asserted-by":"crossref","first-page":"2100425","DOI":"10.1002\/adma.202100425","article-title":"Localized delivery of theranostic nanoparticles and high-energy photons using microneedles-on-bioelectronics","volume":"33","author":"Lee","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0235","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijbiomac.2020.09.170","article-title":"Bioinspired lipid-polysaccharide modified hybrid nanoparticles as a brain-targeted highly loaded carrier for a hydrophilic drug","volume":"165","author":"Omar","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102996_bb0240","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2026.102996_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.nano.2026.102996_bb0250","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1021\/acsnano.5c20622","article-title":"Intranasal conformal patch for sustained levodopa delivery and reactive oxygen species scavenging in Parkinson\u2019s disease","volume":"20","author":"Li","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102996_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.matlet.2025.139973","article-title":"Salicylic acid delivery from nose to brain with three-dimensionally produced microneedles: a potential approach to migraine treatment","volume":"406","author":"Atukeren","year":"2026","journal-title":"Mater Lett"},{"key":"10.1016\/j.nano.2026.102996_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113779","article-title":"Cinnarizine dissolving microneedles against microwave-induced brain injury","volume":"155","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2026.102996_bb0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10837450.2024.2342965","article-title":"Dissolving microneedles loaded with nimodipine for prevention of sleep disorders at a high altitude","volume":"29","author":"Wang","year":"2024","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.nano.2026.102996_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125653","article-title":"Dissolving microneedle patch integrated with microparticle depots for sustained intradermal delivery of donepezil","volume":"678","author":"Lee","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102996_bb0275","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/acs.molpharmaceut.4c00377","article-title":"Fabrication of hybrid coated microneedles with donepezil utilizing digital light processing and semisolid extrusion printing for the management of Alzheimer\u2019s disease","volume":"21","author":"Monou","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.102996_bb0280","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2024.01.030","article-title":"Dual engine-driven bionic microneedles for early intervention and prolonged treatment of Alzheimer\u2019s disease","volume":"367","author":"Zhang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102996_bb0285","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s13346-024-01656-0","article-title":"Transdermal delivery of resveratrol loaded solid lipid nanoparticle as a microneedle patch: a novel approach for the treatment of Parkinson\u2019s disease","volume":"15","author":"Bandiwadekar","year":"2025","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2026.102996_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125418","article-title":"Zein-maltodextrin nanocomplex based dissolving microneedle: a promising approach for paliperidone palmitate delivery","volume":"244","author":"Londhe","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102996_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118962","article-title":"Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention","volume":"575","author":"Xiao","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102996_bb0300","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/ijms27010373","article-title":"The TRiC\/CCT complex at the crossroads of metabolism and hypoxia in GBM: implications for IDH-dependent therapeutic targeting","volume":"27","author":"Alberti","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.nano.2026.102996_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13046-025-03484-7","article-title":"CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-\u03baB and MAPK pathways","volume":"44","author":"He","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.102996_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-025-00274-7","article-title":"Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axis","volume":"6","author":"Qiao","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.nano.2026.102996_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101214","article-title":"Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma","volume":"80","author":"Sun","year":"2025","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.nano.2026.102996_bb0320","doi-asserted-by":"crossref","first-page":"21259","DOI":"10.1038\/s41598-025-05866-5","article-title":"SLC10A3 regulates ferroptosis of glioblastoma through the STAT3\/GPX4 pathway","volume":"15","author":"Sun","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102996_bb0325","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/s41401-025-01600-z","article-title":"Targeting PPAR\u03b1 activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.nano.2026.102996_bb0330","article-title":"Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for glioblastoma","author":"Wu","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.nano.2026.102996_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13816","article-title":"Tryptophan metabolic enzyme IL4I1 inhibits ferroptosis by decreasing ubiquitination of Nrf2 via I3P in glioblastoma","volume":"58","author":"Xu","year":"2025","journal-title":"Cell Prolif"},{"key":"10.1016\/j.nano.2026.102996_bb0340","doi-asserted-by":"crossref","first-page":"2402600","DOI":"10.1002\/advs.202402600","article-title":"LncRNA-mediated TPI1 and PKM2 promote self-renewal and chemoresistance in GBM","volume":"11","author":"Yang","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0345","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41420-025-02427-7","article-title":"Combined anti-PD-L1 and anti-VEGFR2 therapy promotes the antitumor immune response in GBM by reprogramming tumor microenvironment","volume":"11","author":"Yao","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.nano.2026.102996_bb0350","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41419-025-07771-1","article-title":"EGFRvIII-positive glioblastoma contributes to immune escape and malignant progression via the c-fos-MDK-LRP1 axis","volume":"16","author":"Yuan","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nano.2026.102996_bb0355","doi-asserted-by":"crossref","first-page":"2412152","DOI":"10.1002\/advs.202412152","article-title":"Perillaldehyde improves Parkinson-like deficits by targeting G3BP mediated stress granule assembly in preclinical models","volume":"12","author":"Fang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202515138","article-title":"Targeting microglial CD49a inhibits neuroinflammation and demonstrates therapeutic potential for Parkinson\u2019s disease","volume":"13","author":"Lu","year":"2026","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0365","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2025.1687","article-title":"Ambroxol as a treatment for Parkinson\u2019s disease dementia: a randomized clinical trial","volume":"82","author":"Silveira","year":"2025","journal-title":"Jama Neurol"},{"key":"10.1016\/j.nano.2026.102996_bb0370","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.adp3645","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease","volume":"387","author":"Wu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.nano.2026.102996_bb0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-026-00925-5","article-title":"Targeting tau in Alzheimer\u2019s disease: rationale, approach and challenges","volume":"21","author":"Aslanyan","year":"2026","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.nano.2026.102996_bb0380","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nano.2026.102996_bb0385","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1002\/alz.14047","article-title":"PKC\u03b4 serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer\u2019s disease","volume":"20","author":"Du","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.nano.2026.102996_bb0390","article-title":"Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer\u2019s disease phenotypes in mouse models","author":"Feng","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2026.102996_bb0395","doi-asserted-by":"crossref","first-page":"2001355","DOI":"10.1002\/adem.202001355","article-title":"Hollow microneedle arrays produced by low-cost, high-fidelity replication of hypodermic needles tips for high-dose transdermal drug delivery","volume":"23","author":"Zhou","year":"2021","journal-title":"Adv Eng Mater"},{"key":"10.1016\/j.nano.2026.102996_bb0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"Mael\u00edosa","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102996_bb0405","series-title":"Code of Federal Regulations","article-title":"21 CFR part 3 \u2014 product jurisdiction","author":"U.S. Food and Drug Administration","year":"2024"},{"key":"10.1016\/j.nano.2026.102996_bb0410","author":"National Medical Products Administration (NMPA)"},{"key":"10.1016\/j.nano.2026.102996_bb0415","first-page":"1","article-title":"Regulation (EU) 2017\/745 of 5 April 2017 on medical devices, amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and repealing Council Directives 90\/385\/EEC and 93\/42\/EEC","volume":"L117","author":"European Parliament","year":"2017","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.nano.2026.102996_bb0420","author":"National Medical Products Administration (NMPA)"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:13:06Z","timestamp":1788606786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":84,"alternative-id":["S1549963426000973"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102996","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microneedle-mediated drug delivery systems for brain diseases","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102996"}}